Pressure BioSciences, Inc. to Present At the ValueRich Small-Cap Financial Conference and Expo
WEST BRIDGEWATER, Mass., March 20, 2007 (PRIME NEWSWIRE) -- Pressure BioSciences, Inc. (Nasdaq:PBIO) today announced that it will present at the ValueRich Small-Cap Financial Conference and Expo to be held at the Hotel InterContinental, Miami, FL from March 27-28, 2007. Mr. Richard T. Schumacher, PBI President and CEO, will give a corporate overview at 10:50 am (EDT) in the Escorial Room, on March 27th. Investors will be able to see and hear the presentations in real time and for approximately 60 days thereafter at http://www.visualwebcaster.com/ValueRichMiami07/reg.html.
About Pressure BioSciences, Inc.
Pressure BioSciences, Inc. (PBI) is a publicly traded, early-stage company focused on the development of a novel, enabling technology called Pressure Cycling Technology (PCT). PCT uses cycles of hydrostatic pressure between ambient and ultra-high levels (up to 35,000 psi and greater) to control bio-molecular interactions. PBI currently holds 13 U.S. and 5 foreign patents covering multiple applications of PCT in the life sciences field, including such areas as genomic and proteomic sample preparation, pathogen inactivation, the control of enzymes, immunodiagnostics, and protein purification.
Statements contained in this press release regarding the Company's intentions, hopes, beliefs, expectations, or predictions of the future are "forward-looking'' statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based upon the Company's current expectations, forecasts, and assumptions that are subject to risks, uncertainties, and other factors that could cause actual outcomes and results to differ materially from those indicated by these forward-looking statements. These risks, uncertainties, and other factors include, but are not limited to, the risks and uncertainties discussed under the heading "Risk Factors" in the Company's Quarterly Report on Form 10-QSB for the quarter ended September 30, 2006, in the Company's Annual Report on Form 10-KSB, as amended, for the year ended December 31, 2005, and other reports filed by the Company from time to time with the SEC. The Company undertakes no obligation to update any of the information included in this release, except as otherwise required by law.
Visit us at our website http://www.pressurebiosciences.com
CONTACT: Pressure BioSciences, Inc. Investor Contacts: Richard T. Schumacher, President & CEO Edward H. Myles, Sr. Vice President of Finance & CFO (508) 580-1818
Released March 20, 2007